Back to results
US 2015/0105424 A1Published application
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
AssigneeAcelRx Pharmaceuticals, Inc.
InventorsPamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
Life of this patent
Estimating the term…
Abstract
Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
Claims18
1-25. (canceled)
A method of treating pain in a subject, comprising administering a bioadhesive dosage form to the oral mucosa of a subject, wherein said bioadhesive dosage form comprises:
- from about 2 micrograms to about 200 micrograms sufentanil, wherein said dosage form is bioadhesive and has a volume of less than 30 microliters or a mass of less than 30 mg.
Dependencies are inferred from the claim text.